AIMS: To assess the additional discriminative value of adding each of five inflammatory biomarkers to the ASSIGN risk score, which includes social deprivation. METHODS AND RESULTS: In this study, 1319 men and women aged 25-64 in the fourth Glasgow MONICA study were followed-up for cardiovascular endpoints. Baseline C-reactive protein, fibrinogen, IL-6, IL-18, and TNFα were related to risk of CVD. The discriminative value of adding each to the ASSIGN score was assessed using area under the receiver operating characteristic (AUC) and relative integrated percentage improvement in classification (RIDI). During a median of 10.5 years, 151 CVD events occurred. After adjusting for ASSIGN variables, each inflammatory marker except IL-18 had a significant (P < 0.05) association with CVD risk. The AUC using ASSIGN [0.799 (95% CI 0.790-0.809)] was improved by the inclusion of C-reactive protein and TNFα [0.805 (95% CI 0.795-0.815); P < 0.03], but not by other combinations. C-reactive protein and TNFα yielded a significant RIDI (IL-6 almost so). C-reactive protein and TNFα together improved the classification of risk by 11% (95% CI, 3-19%) when added to the ASSIGN variables. CONCLUSION: Some inflammatory biomarkers add moderate discriminative information to the ASSIGN CVD risk score. The clinical utility of this information, cost-effectiveness, and optimization should be assessed in future studies.
AIMS: To assess the additional discriminative value of adding each of five inflammatory biomarkers to the ASSIGN risk score, which includes social deprivation. METHODS AND RESULTS: In this study, 1319 men and women aged 25-64 in the fourth Glasgow MONICA study were followed-up for cardiovascular endpoints. Baseline C-reactive protein, fibrinogen, IL-6, IL-18, and TNFα were related to risk of CVD. The discriminative value of adding each to the ASSIGN score was assessed using area under the receiver operating characteristic (AUC) and relative integrated percentage improvement in classification (RIDI). During a median of 10.5 years, 151 CVD events occurred. After adjusting for ASSIGN variables, each inflammatory marker except IL-18 had a significant (P < 0.05) association with CVD risk. The AUC using ASSIGN [0.799 (95% CI 0.790-0.809)] was improved by the inclusion of C-reactive protein and TNFα [0.805 (95% CI 0.795-0.815); P < 0.03], but not by other combinations. C-reactive protein and TNFα yielded a significant RIDI (IL-6 almost so). C-reactive protein and TNFα together improved the classification of risk by 11% (95% CI, 3-19%) when added to the ASSIGN variables. CONCLUSION: Some inflammatory biomarkers add moderate discriminative information to the ASSIGN CVD risk score. The clinical utility of this information, cost-effectiveness, and optimization should be assessed in future studies.
Authors: Mark Woodward; Hugh Tunstall-Pedoe; G David Batty; Roger Tavendale; Frank B Hu; Sébastien Czernichow Journal: Eur Heart J Date: 2011-02-22 Impact factor: 29.983
Authors: Barbara J M H Jefferis; Olia Papacosta; Christopher G Owen; S Goya Wannamethee; Steve E Humphries; Mark Woodward; Lucy T Lennon; Andrew Thomson; Paul Welsh; Ann Rumley; Gordon D O Lowe; Peter H Whincup Journal: Atherosclerosis Date: 2011-03-24 Impact factor: 5.162
Authors: Peter S Sever; Neil R Poulter; Choon L Chang; Aroon Hingorani; Simon A Thom; Alun D Hughes; Paul Welsh; Naveed Sattar Journal: Eur Heart J Date: 2011-07-28 Impact factor: 29.983
Authors: Stephen Kaptoge; Sreenivasa Rao Kondapally Seshasai; Pei Gao; Daniel F Freitag; Adam S Butterworth; Anders Borglykke; Emanuele Di Angelantonio; Vilmundur Gudnason; Ann Rumley; Gordon D O Lowe; Torben Jørgensen; John Danesh Journal: Eur Heart J Date: 2013-09-10 Impact factor: 29.983
Authors: Ben Schöttker; Christian Herder; Dietrich Rothenbacher; Michael Roden; Hubert Kolb; Heiko Müller; Hermann Brenner Journal: Diabetes Care Date: 2013-02-01 Impact factor: 19.112